Literature DB >> 15870578

How to interpret a healthcare economic analysis.

Melissa M Brown1, Gary C Brown.   

Abstract

PURPOSE: The purpose of the review is to present guidelines to help the clinician to interpret healthcare economic analyses and review pertinent recent analysis in the ophthalmic literature. RECENT
FINDINGS: There are four variants of healthcare economic analyses: (1) cost-minimization analysis; (2) cost-benefit analysis; (3) cost-effectiveness analysis and (4) cost-utility analysis. Cost-utility utility analysis has assumed an increasingly important role in healthcare, with increasing number of analyses occurring in the peer-reviewed ophthalmic literature. These include cost-utility analyses of cataract surgery in the first and second eyes, amblyopia treatment, and cost-utility analyses encompassing the vitreoretinal interventions of the following: (1) laser photocoagulation for exudative macular degeneration; (2) laser treatment for diabetic retinopathy; (3) laser photocoagulation for branch retinal vein obstruction; (4) diabetic vitrectomy; (5) treatment of proliferative retinopathy of prematurity and (6) treatment of retinal detachment associated with proliferative vitreoretinopathy. As an increasing number of cost-utility analyses become available they will provide the information system for the practice of value-based medicine, or medicine based upon the patient-perceived value conferred by interventions.
SUMMARY: Increasing numbers of cost-utility analysis in the ophthalmic literature suggest that ophthalmic interventions, including vitreoretinal interventions, are cost effective. Cost-utility analysis is a major tool in value-based medicine, the practice of medicine based upon the patient-perceived value conferred by healthcare interventions.

Entities:  

Mesh:

Year:  2005        PMID: 15870578

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  Cost effectiveness of the type II Boston keratoprosthesis.

Authors:  J D Ament; T P Stryjewski; S Pujari; S Siddique; G N Papaliodis; J Chodosh; C H Dohlman
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Phacoemulsification versus extracapsular extraction: governmental costs.

Authors:  Newton Kara; Maysa Godoy Gomes Mazurek Sirtoli; Marcony Rodrigues Santhiago; Tais Renata Ribeira Parede; Rodrigo França de Espíndola; Regina de Souza Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 3.  The economic burden of blindness in Pakistan: a socio-economic and policy imperative for poverty reduction strategies.

Authors:  Haroon Awan; Sadia Mariam Malik; Niaz Ullah Khan
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

4.  The development of a public optometry system in Mozambique: a Cost Benefit Analysis.

Authors:  Stephen Thompson; Kovin Naidoo; Geoff Harris; Luigi Bilotto; Jorge Ferrão; James Loughman
Journal:  BMC Health Serv Res       Date:  2014-09-23       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.